Trials / Completed
CompletedNCT01962454
A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers
A Pilot Study in Healthy Male Volunteers to Evaluate a Skeletal-Muscle Microbiopsy Technique for Suitability of Use With Dynamic Proteomic Measurement
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Male
- Age
- 60 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This is a single-blind, randomized placebo-controlled, parallel study, where the study volunteers will be blinded to testosterone/placebo treatment. This study will test a relatively new, less invasive method for collecting muscle tissue to determine if this method is appropriate for collecting muscle samples for the assessment of the fractional synthetic rates (FSR) of muscle-derived proteins. This study will also investigate whether the FSR of proteins may serve as early biomarkers for muscle anabolism, a known anabolic agent (testosterone) will be administered to healthy, elderly male subjects over a 3 week period. The fractional synthetic rate of several muscle-derived proteins will be analyzed at Baseline and during the period of testosterone treatment using deuterium labelling of these proteins by the incorporation of deuterium from deuterated water (D2O).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Deuterated Water | D2O 70% will be supplied as clear liquid, provided in 50 millilitre (mL) unit dose vials; administered per orally. |
| DRUG | Testosterone enanthate | Testosterone enanthate 125mg injection will be supplied as colorless to pale yellow liquid; administered intramuscular (IM). |
| DRUG | Placebo to match testosterone enanthate | Placebo to match testosterone enanthate 0.625 mL injection will be supplied as greenish yellow, bright and clear oily liquid; administered intramuscular (IM). |
Timeline
- Start date
- 2014-05-05
- Primary completion
- 2015-03-20
- Completion
- 2015-03-20
- First posted
- 2013-10-14
- Last updated
- 2017-05-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01962454. Inclusion in this directory is not an endorsement.